Concord Wealth Partners’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$95.9K Buy
+1,941
New +$98.5K 0.01% 292
2026
Q1
Sell
-1,936
Closed -$120K 474
2025
Q4
$120K Buy
1,936
+2
+0.1% +$123 0.02% 236
2025
Q3
$116K Buy
1,934
+2
+0.1% +$122 0.02% 245
2025
Q2
$121K Buy
1,932
+1
+0.1% +$60 0.02% 251
2025
Q1
$116K Buy
1,931
+2
+0.1% +$124 0.02% 227
2024
Q4
$113K Sell
1,929
-227
-11% -$13.5K 0.02% 242
2024
Q3
$128K Buy
2,156
+173
+9% +$9.88K 0.02% 243
2024
Q2
$111K Buy
1,983
+62
+3% +$3.47K 0.02% 235
2024
Q1
$113K Buy
1,921
+1
+0.1% +$56 0.02% 261
2023
Q4
$104K Buy
1,920
+8
+0.4% +$391 0.02% 273
2023
Q3
$92.8K Sell
1,912
-318
-14% -$16.9K 0.02% 295
2023
Q2
$126K Buy
2,230
+1
+0% +$55 0.03% 247
2023
Q1
$120K Buy
2,229
+1
+0% +$53 0.03% 226
2022
Q4
$117K Buy
+2,228
New +$113K 0.04% 224
2022
Q3
Sell
-3,013
Closed -$152K 610
2022
Q2
$152K Buy
3,013
+2
+0.1% +$109 0.04% 195
2022
Q1
$184K Hold
3,011
0.05% 190
2021
Q4
$198K Buy
3,011
+2,159
+253% +$138K 0.05% 192
2021
Q3
$53K Sell
852
-1,050
-55% -$67K 0.02% 213
2021
Q2
$114K Sell
1,902
-1,020
-35% -$59K 0.03% 215
2021
Q1
$161K Sell
2,922
-28,380
-91% -$1.57M 0.05% 150
2020
Q4
$1.71M Buy
+31,302
New +$1.64M 1.32% 12

Other funds holding IHI

Concord Wealth Partners's IHI Position: Q2 2026 in Review

Concord Wealth Partners opened a new position in iShares US Medical Devices ETF (IHI) in Q2 2026: 1,941 shares worth $95.9K. The stake represents 0.01% of the portfolio and ranks #292 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in IHI as recently as Q4 2025.

Concord Wealth Partners first reported a position in IHI in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.71M in Q4 2020. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Concord Wealth Partners held 1,941 shares of iShares US Medical Devices ETF worth $95.9K as of Q2 2026.
  • iShares US Medical Devices ETF was a new Concord Wealth Partners position in Q2 2026.
  • iShares US Medical Devices ETF made up 0.01% of Concord Wealth Partners's portfolio in Q2 2026, its #292 holding.
  • Concord Wealth Partners first reported a position in iShares US Medical Devices ETF in Q4 2020 and has held it in 21 quarters since.
  • Concord Wealth Partners's iShares US Medical Devices ETF position peaked at $1.71M in Q4 2020.
  • 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.